Literature DB >> 12602509

Nitric oxide in liver inflammation and regeneration.

Paloma Martin-Sanz1, Sonsoles Hortelano, Nuria A Callejas, Nora Goren, Marta Casado, Miriam Zeini, Lisardo Boscá.   

Abstract

Hepatocytes express and release inflammatory mediators after challenge with bacterial cell wall molecules and proinflammatory cytokines. Nitric oxide synthase-2 (NOS-2) is expressed under these conditions and the high-output NO synthesis that follows contributes to the inflammatory response in this tissue and participates in the onset of several hepatopathies. However, in the course of liver regeneration, for example, after partial hepatectomy, NOS-2 is expressed at moderate levels and contributes to inhibit apoptosis and to favor progression in the cell cycle until the organ size and function are restored. The mechanisms involved in the regulation of NOS-2 expression under these conditions are revised.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12602509     DOI: 10.1023/a:1021909902310

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  67 in total

1.  Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats.

Authors:  T A Vos; A S Gouw; P A Klok; R Havinga; H van Goor; S Huitema; H Roelofsen; F Kuipers; P L Jansen; H Moshage
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

Review 2.  Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP.

Authors:  E Galea; D L Feinstein
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

3.  Molsidomine increases endotoxic survival and decreases cytokine production.

Authors:  N H Kumins; J Hunt; R L Gamelli; J P Filkins
Journal:  Shock       Date:  1997-03       Impact factor: 3.454

4.  Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase.

Authors:  T Yamashita; S Kawashima; Y Ohashi; M Ozaki; T Ueyama; T Ishida; N Inoue; K Hirata; H Akita; M Yokoyama
Journal:  Circulation       Date:  2000-02-29       Impact factor: 29.690

5.  Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase.

Authors:  S M Hollenberg; M Broussard; J Osman; J E Parrillo
Journal:  Circ Res       Date:  2000-04-14       Impact factor: 17.367

6.  Epr evidence of nitric oxide production by the regenerating rat liver.

Authors:  A F Vanin; P I Mordvintcev; A Mülsch; K Decker
Journal:  Biochem Biophys Res Commun       Date:  1994-07-15       Impact factor: 3.575

7.  Prostaglandin E2 downregulates Kupffer cell production of IL-1 and IL-6 during hepatic regeneration.

Authors:  J A Goss; M J Mangino; M P Callery; M W Flye
Journal:  Am J Physiol       Date:  1993-04

8.  Nitric oxide is released in regenerating liver after partial hepatectomy.

Authors:  S Hortelano; B Dewez; A M Genaro; M J Díaz-Guerra; L Boscá
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

9.  Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor.

Authors:  Y Yamada; E M Webber; I Kirillova; J J Peschon; N Fausto
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

10.  Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide.

Authors:  Q W Xie; R Whisnant; C Nathan
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis.

Authors:  Diana L Diesen; Paul C Kuo
Journal:  J Surg Res       Date:  2009-10-09       Impact factor: 2.192

2.  Kolaviron, a Garcinia biflavonoid complex ameliorates hyperglycemia-mediated hepatic injury in rats via suppression of inflammatory responses.

Authors:  Omolola R Ayepola; Novel N Chegou; Nicole L Brooks; Oluwafemi O Oguntibeju
Journal:  BMC Complement Altern Med       Date:  2013-12-20       Impact factor: 3.659

3.  Selective gene expression profiling contributes to a better understanding of the molecular pathways underlying the histological changes observed after RHMVL.

Authors:  Janine Arlt; Sebastian Vlaic; Ronny Feuer; Maria Thomas; Utz Settmacher; Uta Dahmen; Olaf Dirsch
Journal:  BMC Med Genomics       Date:  2022-10-07       Impact factor: 3.622

4.  Portal Hyperperfusion after Extended Hepatectomy Does Not Induce a Hepatic Arterial Buffer Response (HABR) but Impairs Mitochondrial Redox State and Hepatocellular Oxygenation.

Authors:  Stefan Dold; Sven Richter; Otto Kollmar; Maximilian von Heesen; Claudia Scheuer; Matthias W Laschke; Brigitte Vollmar; Martin K Schilling; Michael D Menger
Journal:  PLoS One       Date:  2015-11-02       Impact factor: 3.240

5.  Oxidative status and the response to pegylated-interferon alpha2a plus ribavirin in chronic genotype 4 HCV hepatitis.

Authors:  Mohammed Mahmound Ahmed; Omar M E Abdel-Salam; Nadia A Mohammed; Dawoud Fakhry Habib; Hewida Ez-Eldin Gomaa
Journal:  EXCLI J       Date:  2013-07-02       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.